UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program

Clinical infectious diseases, 2016-06, Vol.62 (11), p.1380-1389

2016

Volltextzugriff (PDF)

Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study

The Lancet infectious diseases, 2016-06, Vol.16 (6), p.661-673

2016

Volltextzugriff (PDF)

Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial

Clinical infectious diseases, 2019-11, Vol.69 (11), p.1856-1867

2019

Volltextzugriff (PDF)

Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae

Infection control and hospital epidemiology, 2009-12, Vol.30 (12), p.1180-1185

2009

Volltextzugriff (PDF)

Ceftazidime-avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 Randomized Trial Program

Clinical infectious diseases, 2016-09, Vol.63 (6), p.754-762

2016

Volltextzugriff (PDF)

Cefepime–Taniborbactam in Complicated Urinary Tract Infection

The New England journal of medicine, 2024-02, Vol.390 (7), p.611-622

2024

Volltextzugriff (PDF)

Oral Lefamulin vs Moxifloxacin for Early Clinical Response Among Adults With Community-Acquired Bacterial Pneumonia: The LEAP 2 Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2019-11, Vol.322 (17), p.1661

2019

Volltextzugriff (PDF)

Clinical activity of ceftazidime/avibactam against MDR Enterobacteriaceae and Pseudomonas aeruginosa: pooled data from the ceftazidime/avibactam Phase III clinical trial programme

Journal of antimicrobial chemotherapy, 2018-09, Vol.73 (9), p.2519-2523

2018

Volltextzugriff (PDF)

Patient outcomes by baseline pathogen resistance phenotype and genotype in CERTAIN-1, a Phase 3 study of cefepime-taniborbactam versus meropenem in adults with complicated urinary tract infection

Antimicrobial agents and chemotherapy, 2024-07, Vol.68 (7)

2024

Volltextzugriff (PDF)

Impact of different methods for describing the extent of prior antibiotic exposure on the association between antibiotic use and antibiotic-resistant infection

Infection control and hospital epidemiology, 2007-06, Vol.28 (6), p.647-654

2007

Volltextzugriff (PDF)

Contact isolation for infection control in hospitalized patients: is patient satisfaction affected?

Infection control and hospital epidemiology, 2008-03, Vol.29 (3), p.275-278

2008

Volltextzugriff (PDF)

Child care center exclusion policies and directors' opinions on the use of antibiotics

Infection control and hospital epidemiology, 2010-04, Vol.31 (4), p.408-411

2010

Volltextzugriff (PDF)

Clinical and Microbiological Outcomes of Serious Infections with Multidrug-Resistant Gram-Negative Organisms Treated with Tigecycline

Clinical infectious diseases, 2008-02, Vol.46 (4), p.567-570

2008

Volltextzugriff (PDF)

Reply to Johnson

Clinical infectious diseases, 2017-02, Vol.64 (3), p.391-391

2017

Volltextzugriff (PDF)

Stockpiling drugs for an avian influenza outbreak: examining the surge in oseltamivir prescriptions during heightened media coverage of the potential for a worldwide pandemic

Infection control and hospital epidemiology, 2009-04, Vol.30 (4), p.370-376

2009

Volltextzugriff (PDF)

Impact of automatic orders to discontinue vancomycin therapy on vancomycin use in an antimicrobial stewardship program

Infection control and hospital epidemiology, 2007-12, Vol.28 (12), p.1408-1410

2007

Volltextzugriff (PDF)

Coadministration of oral levofloxacin with agents that impair absorption: impact on antibiotic resistance

Infection control and hospital epidemiology, 2008-10, Vol.29 (10), p.975-977

2008

Volltextzugriff (PDF)

Risk factors for and impact of infection or colonization with aztreonam-resistant Pseudomonas aeruginosa

Infection control and hospital epidemiology, 2007-10, Vol.28 (10), p.1175-1180

2007

Volltextzugriff (PDF)

Effect of accessibility of influenza vaccination on the rate of childcare staff vaccination

Infection control and hospital epidemiology, 2008-05, Vol.29 (5), p.465-467

2008

Volltextzugriff (PDF)

Prevention and Treatment of Health Care–Acquired Infections

The Medical clinics of North America, 2008-03, Vol.92 (2), p.295-313

2008

Volltextzugriff (PDF)

Hepatitis C virus seropositivity in organ donors and survival in heart transplant recipients

JAMA : the journal of the American Medical Association, 2006-10, Vol.296 (15), p.1843

2006

Volltextzugriff (PDF)

Effect of tebipenem pivoxil hydrobromide on the normal gut microbiota of a healthy adult population in Sweden: a randomised controlled trial

The Lancet. Microbe, 2024-04, Vol.5 (4), p.e355-e365

2024

Volltextzugriff (PDF)

Low Prevalence of Prior Streptococcus pneumoniae Vaccination Among Potential Lung Transplant Candidates

Chest, 2006-07, Vol.130 (1), p.218-221

2006

Volltextzugriff (PDF)

Fluoroquinolone-Resistant Pseudomonas aeruginosa: Assessment of Risk Factors and Clinical Impact

The American journal of medicine, 2006-06, Vol.119 (6), p.526.e19-526.e25

2006

Volltextzugriff (PDF)

The categorization of prior antibiotic use: Impact on the identification of risk factors for drug resistance in case control studies

American journal of infection control, 2007-12, Vol.35 (10), p.638-642

2007

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Aktive Filter

PublikationsformArtikel

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(22)

Sprache

Englisch
(36)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(31)
Science & Technology
(31)
Humans
(27)
Infectious Diseases
(23)
Biological And Medical Sciences
(17)
Medical Sciences
(17)
Antibiotics
(13)
Middle Aged
(13)
Male
(12)
Adult
(11)
Anti-Bacterial Agents - Therapeutic Use
(11)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(11)
Female
(11)
Microbiology
(11)
Pharmacology. Drug Treatments
(11)
Aged
(10)
Public, Environmental & Occupational Health
(10)
Risk Factors
(9)
Antibacterial Agents
(8)
Infections
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program

Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study

Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial

Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae

Ceftazidime-avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 Randomized Trial Program

Cefepime–Taniborbactam in Complicated Urinary Tract Infection

Oral Lefamulin vs Moxifloxacin for Early Clinical Response Among Adults With Community-Acquired Bacterial Pneumonia: The LEAP 2 Randomized Clinical Trial

Clinical activity of ceftazidime/avibactam against MDR Enterobacteriaceae and Pseudomonas aeruginosa: pooled data from the ceftazidime/avibactam Phase III clinical trial programme

Patient outcomes by baseline pathogen resistance phenotype and genotype in CERTAIN-1, a Phase 3 study of cefepime-taniborbactam versus meropenem in adults with complicated urinary tract infection

Impact of different methods for describing the extent of prior antibiotic exposure on the association between antibiotic use and antibiotic-resistant infection

Contact isolation for infection control in hospitalized patients: is patient satisfaction affected?

Child care center exclusion policies and directors' opinions on the use of antibiotics

Clinical and Microbiological Outcomes of Serious Infections with Multidrug-Resistant Gram-Negative Organisms Treated with Tigecycline

Reply to Johnson

Stockpiling drugs for an avian influenza outbreak: examining the surge in oseltamivir prescriptions during heightened media coverage of the potential for a worldwide pandemic

Impact of automatic orders to discontinue vancomycin therapy on vancomycin use in an antimicrobial stewardship program

Coadministration of oral levofloxacin with agents that impair absorption: impact on antibiotic resistance

Risk factors for and impact of infection or colonization with aztreonam-resistant Pseudomonas aeruginosa

Effect of accessibility of influenza vaccination on the rate of childcare staff vaccination

Prevention and Treatment of Health Care–Acquired Infections

Hepatitis C virus seropositivity in organ donors and survival in heart transplant recipients

Effect of tebipenem pivoxil hydrobromide on the normal gut microbiota of a healthy adult population in Sweden: a randomised controlled trial

Low Prevalence of Prior Streptococcus pneumoniae Vaccination Among Potential Lung Transplant Candidates

Fluoroquinolone-Resistant Pseudomonas aeruginosa: Assessment of Risk Factors and Clinical Impact

The categorization of prior antibiotic use: Impact on the identification of risk factors for drug resistance in case control studies

Aktive Filter

Suchergebnisse filtern